Literature DB >> 29569979

An abscopal effect may augment PD-1 inhibition in refractory classical Hodgkin lymphoma.

Joel C Wight1, Eliza A Hawkes1,2,3,4, Salvatore U Berlangieri1, Richard Khor1,5,6, Andrew P Grigg1,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29569979     DOI： 10.1080/10428194.2018.1452217

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  3 in total

1.  Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study.

Authors:  Stephen M Ansell; Monique C Minnema; Peter Johnson; John M Timmerman; Philippe Armand; Margaret A Shipp; Scott J Rodig; Azra H Ligon; Margaretha G M Roemer; Nishitha Reddy; Jonathon B Cohen; Sarit Assouline; Michelle Poon; Manish Sharma; Kazunobu Kato; Selda Samakoglu; Anne Sumbul; Andrew Grigg
Journal:  J Clin Oncol       Date:  2019-01-08       Impact factor: 44.544

2.  Tumor Microenvironment and Microvascular Density in Follicular Lymphoma.

Authors:  Roberto Tamma; Giuseppe Ingravallo; Tiziana Annese; Francesco Gaudio; Tommasina Perrone; Pellegrino Musto; Giorgina Specchia; Domenico Ribatti
Journal:  J Clin Med       Date:  2022-02-25       Impact factor: 4.241

Review 3.  Immune-Checkpoint Blockade Therapy in Lymphoma.

Authors:  Ayumi Kuzume; SungGi Chi; Nobuhiko Yamauchi; Yosuke Minami
Journal:  Int J Mol Sci       Date:  2020-07-30       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.